4.68

1.47% -0.07

Optimi Health Corp (OPTH)

Overview News Price History Discussions Forecast

Optimi Health Corp stock is traded at $4.68, with a volume of 17,809. It is down -1.47% in the last 24 hours and up +16.71% over the past month. Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.

Previous Close:

$4.75

Open:

$4.7

24h Volume:

17,809

Relative Volume:

0.19

Market Cap:

$26.33M

Revenue:

$257.00K

Net Income/Loss:

$-3.07M

P/E Ratio:

-4.9124

EPS:

-0.9527

Net Cash Flow:

$-1.40M

1W Performance:

-6.59%

1M Performance:

+16.71%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$4.56

$4.8831

1-Week Range:

$4.3001

$5.06

52-Week Range:

$4.00

$6.20

Optimi Health Corp Stock (OPTH) Company Profile

Name

Optimi Health Corp

Sector

Healthcare (1071)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-09-07

Latest SEC Filings

OPTH's Discussions on Twitter

Compare OPTH vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPTH Optimi Health Corp	4.68	26.33M	257.00K	-3.07M	-1.40M	-0.9527
TAK Takeda Pharmaceutical Co Adr	17.24	55.06B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.78	43.07B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.81	35.88B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.35	31.59B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	528.47	26.32B	3.17B	1.29B	1.01B	27.09

Optimi Health Corp Stock (OPTH) Latest News

Jul 22, 2026

SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits

Jul 22, 2026

Jul 20, 2026

Optimi Health (OPTH) CEO boosts stake with 18,700-share buy - Stock Titan

Jul 20, 2026

Optimi Health CEO Dane Stevens raises stake to 452,547 shares after buying 18,700 shares - Bitget

Jul 20, 2026

Jul 17, 2026

Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp - Yahoo! Finance Canada

Jul 17, 2026

Jul 11, 2026

Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules - TMX Newsfile

Jul 11, 2026

Jul 10, 2026

3 Psychedelic Stocks With Potential Clinical Trial Catalysts - Sahm

Jul 10, 2026

Jul 09, 2026

OPTH Price Today: Optimi Health Corp. Stock Price, Quote & Chart - mexc.co

Jul 09, 2026

Jul 07, 2026

Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia - AOL.com

Jul 07, 2026

Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting - AOL.com

Jul 07, 2026

Optimi Health (OPTH) 10K Form and Latest SEC Filings 2026 - MarketBeat

Jul 07, 2026

Jun 30, 2026

Optimi Health Corp. - The Canadian Securities Exchange (CSE)

Jun 30, 2026

Jun 29, 2026